6505--Frozen Intravenous (IV) Antibiotics
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the VA Loma Linda Healthcare System Pharmacy Service, is conducting a Request for Information (RFI) / Sources Sought Notice to identify qualified sources for Frozen Intravenous (IV) Antibiotics. This is for planning purposes to establish a potential firm-fixed-price Indefinite Delivery Indefinite Quantity (IDIQ) contract. Responses are due by June 1, 2026, at 10:00 AM Pacific Time.
Scope of Work
The VA seeks to procure various frozen IV antibiotics, including Cefazolin, Cefepime, Oxacillin, and Ceftriaxone, in specific dosages and packaging. These pharmaceuticals are essential for direct patient care, treating acute or life-threatening conditions. The anticipated contract structure is a firm-fixed-price IDIQ, with a base year (August 20, 2026 – August 19, 2027) and four one-year option periods. Performance will be at the Loma Linda VA Med Center Pharmacy Service in Loma Linda, CA.
Key Requirements
- Product Standards: Medications must be FDA-approved and conform to VA National Formulary standards. Products require a minimum remaining shelf life (e.g., 6 months) at delivery and a certificate of analysis/equivalency upon request.
- Delivery: Delivery must occur within 1-3 business days of order placement to designated units, with shipment tracking and documentation. Invoices must be submitted via Tungsten, matching delivery orders.
- Compliance: Vendors must comply with VA procurement policy, including Drug Supply Chain Security Act (DSCSA) standards.
Submission & Evaluation
Interested companies should submit a capabilities statement detailing how they meet (or cannot meet) the Statement of Work requirements, provide feedback or suggestions on the SOW, and indicate their business size status (e.g., SDVOSB, VOSB, HUBZone, WOSB, Large Business) under NAICS 325412 (size standard 1,300 employees). Additional information requested includes manufacturer/distributor status, subcontracting compliance, COTS confirmation, Buy American Act conformity, lead times, product lifespan, FDA clearance, leasing options, existing Federal contracts (FSS GSA/NAC/SAC/BPA/NASA SEWP), general pricing for market research, and SAM.gov Unique Entity ID/Cage Code. Responses are for planning purposes only and will inform future acquisition decisions.
Additional Notes
This is not a solicitation and does not constitute an offer. All information received will be used for planning purposes only. Responders are responsible for all associated expenses. Further RFIs or solicitations may be published based on the information gathered.